Todd Villines: Coronary Artery Disease – A BIG Movement to Change
Dr. Todd C. Villines, Professor of Cardiology and Vice-Chief of CV Division at the University of Virginia (UVA), posted on X:
”Coronary artery disease: a BIG movement to change from reactive end-stage treatment to early detection and treatment.
Kudos to the The Lancet Commission for actively studying the global health benefits of this paradigm shift from “ischemic” heart disease to atherosclerosis.”
Read the editorial here.
Read the full article here.
Title: The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Authors: Sarah Zaman, Jason H Wasfy, Vikas Kapil, Boback Ziaeian, William A Parsonage, Sira Sriswasdi, Timothy J A Chico, Davide Capodanno, Róisín Colleran, Nadia R Sutton, Lei Song, Nicole Karam, Reecha Sofat, Chiara Fraccaro, Daniel Chamié, Mirvat Alasnag, Takayuki Warisawa, Nieves Gonzalo, Walid Jomaa, Shamir R Mehta, Elizabeth E S Cook, Johan Sundström, Stephen J Nicholls, Leslee J Shaw, Manesh R Patel, Rasha K Al- Lamee
Stay updated with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis